Fact CheckerSign in

NCT05651542Completed

A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease

Source: ClinicalTrials.gov · Last updated 28 Sept 2026

Brief summary (registry, in English)

This study aims to test the feasibility, acceptability, and preliminary efficacy of a comprehensive self-management (CSM) intervention for people with inflammatory bowel disease (IBD). The CSM-IBD intervention is an adaption of the CSM intervention initially developed for individuals with irritable bowel syndrome. The intervention has eight sessions which cover an introduction to IBD, symptom tracking, cognitive behavioral strategies, relaxation, sleep, diet, and pain management.

Status (registry)
Completed
Study type
Interventional
Enrollment
55 (actual)
First submitted
5 Dec 2022
Start date
14 Mar 2023
Primary completion date
30 Sept 2025
Lead sponsor
University of Washington
NCT number
NCT05651542

What you commit to

  • Study type: Interventional
  • Participants enrolled: 55
  • From 14 Mar 2023 to the primary completion date, 30 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Bowel-related surgery within the past month

Other

  • Live outside of Washington state

Who the study is looking for

  • Healthcare provider diagnosis of inflammatory bowel disease
  • Report current symptoms
  • Able to read and write in English

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Washington
Coordinator of this site? Confirm its status
SeattleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.